HS632

· BioRay Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HS632, covering 2025-11-21 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Pharmacokinetics and Safety of HS632 and Xolair® With a Single Injection [Phase 1]